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Abstract: 
 
Background: Leukoencephalopathy with temporal lobe cysts may be associated with 
monogenetic conditions such as Aicardi Goutières Syndrome or RNASET2 mutations, as well 
as with congenital infections such as cytomegalovirus (CMV). In view of the fact that congenital 
CMV is difficult to confirm outside the neonatal period, excluding a Mendelian disorder is 
extremely relevant, changing family planning and medical management in affected families. We 
performed diagnostic testing in individuals with leukoencephalopathy with temporal lobe cysts 
without a definitive diagnosis of congenital CMV infection. 
Methods: We reviewed a large-scale biorepository of patients with unsolved leukodystrophies 
and identified 2 individuals with RMND1 mutations and similar MRI features, including temporal 
lobe cysts. Ten additional subjects with confirmed RMND1 mutations were identified as part of a 
separate disease specific cohort. Brain MRIs from all 12 individuals were reviewed for common 
neuroradiologic features.  
Results: MRI features in RMND1 mutations included temporal lobe swelling, with rarefaction 
and cystic evolution, enlarged tips of the temporal lobes, and multifocal subcortical white matter 
changes with confluent periatrial T2 signal hyperintensity. A combination of these features were 
present in 10 of the 12 individuals reviewed.  
Conclusions: Despite the small number of reported cases with RMND1 mutations, a clinically 
recognizable phenotype of leukoencephalopathy with temporal lobe swelling, rarefaction and 
cystic changes has emerged in a subset of individuals. Careful clinical phenotyping, including 
for lactic acidosis, deafness, and severe muscle involvement seen in RMND1 mutation positive 
individuals, and MRI pattern recognition will be important in differentiating these patients from 
children with congenital infections like CMV. 
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Introduction: 
Although mitochondrial disorders account for a large portion of inherited disease, these continue 
to be a diagnostic challenge due to the vast number of genes that can cause mitochondrial 
dysfunction.  Even with the advent of Next Generation Sequencing (NGS), establishing a 
clinically recognizable phenotype and pathognomonic MRI pattern that can facilitate a diagnosis 
remains important. We identified a small cohort of patients with the previously described 
Combined Oxidative Phosphorylation Deficiency 11 or RMND1 (Required for Meiotic Nuclear 
Division 1) associated encephalopathy (MIM #614922). These patients have distinct MRI 
features that may facilitate the diagnosis of this condition.  
RMND1 encodes an essential membrane protein that is necessary for the normal assembly and 
conservation of mitochondrial ribosomes used in the formation of oxidative phosphorylation 
(OXPHOS) complexes (Janer et al., 2012). In these patients, lactic acidosis, myopathy, and 
renal abnormalities may be attributable to respiratory chain enzyme defects associated with 
RMND1 mutations (Garcia et al., 2012).  More often these individuals may present initially with 
less specific features of severe developmental delay, sensorineural hearing loss, seizures, and 
hypotonia. In these children, clinical and MRI features may overlap with acquired conditions of 
the central nervous system, such as congenital infections including cytomegalovirus (CMV) (van 
der Knaap et al., 2004).  
To alert clinicians to the specific MRI features seen in a subset of individuals with RMND1-
associated encephalopathy, and to expand the list of monogenetic disorders that may mimic 
acquired perinatal infections, we review the MRI and clinical features of 12 individuals with 
RMND1 mutation confirmed mitochondrial encephalopathy. 
Methods:  
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A cohort of mutation positive individuals was ascertained from the Myelin Disorders Bioregistry 
Project (MDBP), an IRB approved bioregistry at Children’s National, which combines clinical, 
molecular and radiological data in cases of unsolved leukoencephalopathy (patients 1, 2, 9 and 
10). After characterization of clinical and MRI features in the initial cohort, a second cohort of 
mutation-proven individuals from outside centers was identified for validation of the findings. 
Clinical features of patients 1-4, 7-10, and 12 were published before or during this period of 
characterization (Janer et al., 2015, Ng et al., 2016). Patients 5,6, and 11 are newly reported 
(Table 1).  
MRIs were scored according to a standard protocol for extent and localization of white matter 
abnormalities as well as cystic changes in the temporal lobe or elsewhere (van der Knaap et al., 
1999). Descriptive analysis of clinical and MRI features was performed due to the small size of 
these cohorts. 
Results: 
In the MDBP, 2 individuals with temporal lobe cysts and leukoencephalopathy from the same 
family underwent NGS approaches (Table 1). RMND1 mutations were isolated in these 
individuals using Whole Exome Sequencing (WES) (Vanderver et al., 2016). We obtained 8 
additional RMND1 mutation positive individuals (Table 1) from published and unpublished 
reports. Ten of the 12 individuals demonstrated shared neuroradiologic features (Figure 1) 
including temporal lobe swelling with cystic evolution (Table 2). Of note, in 6 of these 12 
individuals, temporal lobe findings were asymmetric, affecting only one temporal lobe.  In 6 of 
the 7 individuals over 1 year of age and in whom myelination could be more reliably assessed, 
we also identified multifocal subcortical white matter changes with confluent periatrial T2 signal 
hyperintensity.  A subset of patients (4/12) also had dilation of the temporal horns, and thinning 
of the corpus callosum (8/12). 
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Clinical findings (Table 2) from individuals within our cohort mimic those previously identified in 
published cases of individuals with RMND1 mutations, including cognitive developmental delay 
(12/12), hypotonia (12/12), sensorineural hearing loss (12/12) and seizures (6/12). Additionally, 
most individuals exhibit renal abnormalities (10/12) and lactic acidosis (11/12), though this was 
in some cases recognized only after RMND1 mutations were identified. 
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Case 
Number 
Age at 
Symptom 
Onset 
Develop-
mental 
Delay 
Autistic 
Spectrum 
Disorder 
Sensori-
neural 
Hearing 
Loss 
Seizures Hypotonia Lactic Acidosis 
Renal 
Abnormalities 
Age 
at 
Death 
Variants 
(NM_017909.3) 
1* 2y + + + *+ + + - NA 
Homozygous  
c.713A>G 
p.(Asn238Ser) 
2* N + + + *+ + - - NA 
Homozygous 
c.713A>G 
p.(Asn238Ser) 
3* N + - + - + + + 5 y 9 
mo 
Homozygous 
c.1349G>C 
p.(*450Serext*31) 
4* N + - + - + + + 6 mo 
Homozygous 
c.1349G>C 
p.(*450Serext*31) 
5 N + - + - + + + NA 
c.533C>T 
p.(Thr178Met)  and 
c.713A>G 
p.(Asn238Ser)     
6 2 mo + - + - + + + NA 
c.533C>T 
p.(Thr178Met)  and 
c.713A>G 
p.(Asn238Ser)   
7* 6 mo + UNK + - + + + 1 y 4 
mo 
Homozygous 
c.1349G>C 
p.(*450Serext*31) 
8** P + - + + + + + 4 y 2 
mo 
c.613G>T 
p.(Asp205Tyr) and 
c.713A>G 
p.(Asn238Ser) 
9* 4 mo + + + + + + + NA 
Homozygous 
c.713A>G 
p.(Asn238Ser) 
10* N + - + - + + + NA 
c.713A>G 
p.(Asn238Ser) and 
c.1317+1G>T 
11 P + - + + + + + 21 
mos 
c.713A>G 
p.(Asn238Ser) and 
c.485del 
p.(Pro162Glnfs*5) 
12* 2 mo + - + + + + + NA 
c.713A>G 
p.(Asn238Ser) and  
c.1303C>T 
p.(Leu435Phe) 
 
 
 
          
           
KEY: + =  Symptoms Present; - = Symptoms Absent; *+ = Febrile Seizure; mo = months; y = years; 
UNK = UNKNOWN; NA = Not Applicable; N = Neonatal Period; P = Prenatal Period. Variant 
positions relative to transcript NM_017909.3. 
*(Ng et al., 2016) 
**(Janer et al., 2015) 
* 
Table 1: Clinical Manifestations 
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Case Number  Age 
Temporal 
predominance 
of white matter 
abnormalities 
Multifocal 
subcortical 
or diffuse 
white matter 
involvement 
Periatrial T2 
hyperintensity 
Temporal 
lobe 
swelling 
Temporal 
horn 
dilation 
Temporal 
cystic 
changes  
Thinning of 
the 
posterior 
CC 
1 2 y + + + + + + + 
2 7 mo + NQ + + + + + 
3 1 y 4 mo - - + - - - - 
4 6 mo + NQ NQ - - +* - 
5 8 y 2 mo + + + +* - +* + 
6 1 y 8 mo + + + + + + + 
7 1 y - NQ + - - - - 
8 1 y 11 mo + + + - - +* + 
9 2 y 1 mo + + + + - +* + 
10 9 mo + NQ - - - +* - 
11 1 y 5 mo  + + + + - + + 
12 1 y + NQ NQ + + +* + 
 
 
 
        
         
         
Table 2: Neuroradiologic Features 
KEY: + = Symptoms Present; - = Symptoms Absent; mo = months; y = years; * = unilateral; CC = Corpus Callosum; NQ = not 
quantifiable as immature myelination in a child <1 year 
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Discussion: 
MRI pattern recognition is invaluable when differentiating between individual 
leukoencephalopathies (van der Knaap et al., 2004). Features of leukoencephalopathy with 
temporal lobe cysts have been associated with a number of congenital infections, including 
most notably congenital CMV, but have also been seen in early onset genetic 
leukoencephalopathies including Aicardi-Goutières Syndrome and RNASET2 deficiency(van der 
Knaap et al., 2004, Henneke et al., 2009, Vanderver et al., 2015). Differential diagnosis is 
further complicated because most individuals with leukoencephalopathy with temporal lobe 
cysts are identified in the post-natal setting, when a diagnosis of a congenital infection is difficult 
to establish. Thus, it is imperative to establish Mendelian mimickers of neurologic injury from 
congenital infection. 
A diagnosis of RMND1 related encephalopathy has implications for medical management, 
including risks for sensorineural hearing loss, renal disease and lactic acidosis. These features 
were present in the patients within our cohort, as well as other patients currently identified in the 
literature(Garcia-Diaz et al., 2012, Janer et al., 2012, Janer et al., 2015). Although patients may 
present with these features, and a mitochondrial cytopathy may be suggested, they may also 
present with more subtle features of developmental delay and hypotonia.  
In this cohort, a majority of individuals had findings of temporal lobe involvement, with cystic 
changes, along with a multifocal subcortical leukoencephalopathy. These imaging features may 
be seen in both acquired and genetic etiologies, and RMND1 related encephalopathy should be 
considered in the differential diagnosis of this radiologic presentation. 
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Figure Legend 
Figure 1.  T2 and T2-FLAIR weighted imaging in Patient 1 (A, at 8 months), Patient 2 (B and 
bottom insert in C, at 8 months) and Patient 5 (C, at 8 years) demonstrating temporal lobe 
swelling (on axial view dotted white arrow, A, and on sagittal view thick white arrow, insert C) 
with cystic rarefaction (black arrow A). Also notable is dilatation of the tip of the temporal 
ventricle (on axial views, white arrow B and thin white arrow in insert of C) and thinning of the 
corpus callosum. Patients additionally may have multifocal white matter changes (A and dotted 
white arrow C). 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
References: 
GARCIA-DIAZ, B., BARROS, M. H., SANNA-CHERCHI, S., EMMANUELE, V., AKMAN, H. O., FERREIRO-
BARROS, C. C., HORVATH, R., TADESSE, S., EL GHARABY, N., DIMAURO, S., DE VIVO, D. C., SHOKR, 
A., HIRANO, M. & QUINZII, C. M. 2012. Infantile encephaloneuromyopathy and defective 
mitochondrial translation are due to a homozygous RMND1 mutation. Am J Hum Genet, 91, 729-
36. 
HENNEKE, M., DIEKMANN, S., OHLENBUSCH, A., KAISER, J., ENGELBRECHT, V., KOHLSCHUTTER, A., 
KRATZNER, R., MADRUGA-GARRIDO, M., MAYER, M., OPITZ, L., RODRIGUEZ, D., RUSCHENDORF, 
F., SCHUMACHER, J., THIELE, H., THOMS, S., STEINFELD, R., NURNBERG, P. & GARTNER, J. 2009. 
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain 
infection. Nat Genet, 41, 773-5. 
JANER, A., ANTONICKA, H., LALONDE, E., NISHIMURA, T., SASARMAN, F., BROWN, G. K., BROWN, R. M., 
MAJEWSKI, J. & SHOUBRIDGE, E. A. 2012. An RMND1 Mutation causes encephalopathy 
associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial 
translation defect. Am J Hum Genet, 91, 737-43. 
JANER, A., VAN KARNEBEEK, C. D., SASARMAN, F., ANTONICKA, H., AL GHAMDI, M., SHYR, C., DUNBAR, 
M., STOCKLER-ISPIROGLU, S., ROSS, C. J., VALLANCE, H., DIONNE, J., WASSERMAN, W. W. & 
SHOUBRIDGE, E. A. 2015. RMND1 deficiency associated with neonatal lactic acidosis, infantile 
onset renal failure, deafness, and multiorgan involvement. Eur J Hum Genet, 23, 1301-7. 
NG, Y. S., ALSTON, C. L., DIODATO, D., MORRIS, A. A., ULRICK, N., KMOCH, S., HOUSTEK, J., MARTINELLI, 
D., HAGHIGHI, A., ATIQ, M., GAMERO, M. A., GARCIA-MARTINEZ, E., KRATOCHVILOVA, H., 
SANTRA, S., BROWN, R. M., BROWN, G. K., RAGGE, N., MONAVARI, A., PYSDEN, K., RAVN, K., 
CASEY, J. P., KHAN, A., CHAKRAPANI, A., VASSALLO, G., SIMONS, C., MCKEEVER, K., O'SULLIVAN, 
S., CHILDS, A. M., OSTERGAARD, E., VANDERVER, A., GOLDSTEIN, A., VOGT, J., TAYLOR, R. W. & 
MCFARLAND, R. 2016. The clinical, biochemical and genetic features associated with RMND1-
related mitochondrial disease. J Med Genet. 
VAN DER KNAAP, M. S., BREITER, S. N., NAIDU, S., HART, A. A. & VALK, J. 1999. Defining and categorizing 
leukoencephalopathies of unknown origin: MR imaging approach. Radiology, 213, 121-33. 
VAN DER KNAAP, M. S., VERMEULEN, G., BARKHOF, F., HART, A. A., LOEBER, J. G. & WEEL, J. F. 2004. 
Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing 
of Guthrie cards to link pattern with congenital cytomegalovirus infection. Radiology, 230, 529-
36. 
VANDERVER, A., PRUST, M., KADOM, N., DEMAREST, S., CROW, Y. J., HELMAN, G., ORCESI, S., LA PIANA, 
R., UGGETTI, C., WANG, J., GORDISCH-DRESSMAN, H., VAN DER KNAAP, M. S. & LIVINGSTON, J. 
H. 2015. Early-Onset Aicardi-Goutieres Syndrome: Magnetic Resonance Imaging (MRI) Pattern 
Recognition. J Child Neurol, 30, 1343-8. 
VANDERVER, A., SIMONS, C., HELMAN, G., CRAWFORD, J., WOLF, N. I., BERNARD, G., PIZZINO, A., 
SCHMIDT, J. L., TAKANOHASHI, A., MILLER, D., KHOUZAM, A., RAJAN, V., RAMOS, E., 
CHOWDHURY, S., HAMBUCH, T., RU, K., BAILLIE, G. J., GRIMMOND, S. M., CALDOVIC, L., 
DEVANEY, J., BLOOM, M., EVANS, S. H., MURPHY, J. L., MCNEILL, N., FOGEL, B. L., 
LEUKODYSTROPHY STUDY, G., SCHIFFMANN, R., VAN DER KNAAP, M. S. & TAFT, R. J. 2016. 
Whole exome sequencing in patients with white matter abnormalities. Ann Neurol, 79, 1031-7. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
